Taysha collaborates on minigene payloads for AAV gene therapy

By The Science Advisory Board staff writers

February 9, 2021 -- Taysha Gene Therapies has established multiyear collaborations with the Cleveland Clinic and the University of Texas Southwestern (UTSW) Gene Therapy Program to advance next-generation minigene payloads for adeno-associated virus (AAV) gene therapies.

The new gene therapies will be used for the treatment of genetic epilepsies and additional central nervous system disorders. Taysha will have an exclusive option on the new payloads, constructs, and intellectual property associated with, and arising from, the research conducted under the agreement.

Researchers at the Cleveland Clinic Lerner Research Institute will create minigene payloads designed to address the limitations of vector packaging capacity in AAV gene therapy. UTSW will create and evaluate vector constructs for in vivo and in vitro efficacy.

Taysha, UTSW start fund to speed up CNS gene therapies
Taysha Gene Therapies and the University of Texas Southwestern Medical Center (UTSW) have launched a fund to accelerate the development of adeno-associated...
AllStripes, Taysha Gene Therapies partner on rare disease gene therapy program
AllStripes and Taysha Gene Therapies have entered a multiyear collaboration focused on advancing the development of TSHA-104, an adeno-associated virus...
Taysha nabs rare pediatric disease, orphan drug status
Taysha Gene Therapies has received rare pediatric disease designation and orphan drug designation from the U.S. Food and Drug Administration for TSHA-104,...
Taysha gets $95M in financing to advance gene therapies
Taysha Gene Therapies has closed on $95 million in series B financing to advance gene therapies for monogenic central nervous system diseases.

Copyright © 2021 scienceboard.net

Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
International Society for Pharmaceutical Engineering Annual Meeting
October 30 - November 2
Orlando, Florida United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter